// App-Quantinova.ai

2431 : Enrichment of targetable mutations in the relapsed neuroblastoma genome

Researchers

Presenter

  • Olivia M. Padovan-Merhar

Principal Investigators

  • Pichai Raman

  • Kaitlyn R. Rubnitz

  • Siraj M. Ali

  • Vincent A. Miller

  • Yael P. Mosse

  • Meaghan P. Granger

  • Brian D. Weiss

  • John M. Maris

  • Shakeel Modak

Medical Centers

  • Childrens Hospital of Philadelphia, Philadelphia, PA

  • Foundation Medicine, Inc, Cambridge, MA

  • Cook Children's Health Care System, Fort Worth, TX

  • Cincinnati Children's Hospital, Cincinnati, OH

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • Foundation Medicine,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • Anaplastic lymphoma Kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved